Related Experiment Videos
HLA-B*5101 in Greek patients with Behçet's disease
Y Koumantaki1, C Stavropoulos, M Spyropoulou
1University of Athens Medical School, Goudi, Greece.
Human Immunology
|May 6, 1998
Summary
The HLA-B51 allele, specifically B*5101, is a significant predisposing genetic marker for Behçet's disease (BD) in the Greek population. This allele is associated with earlier disease onset and increased risk of erythema nodosum.
Area of Science:
- Immunogenetics
- Rheumatology
- Systemic Vasculitis
Background:
- Behçet's disease (BD) is a recurrent systemic vasculitis with unknown etiology.
- Genetic factors, particularly HLA associations, are implicated in BD pathogenesis.
- Previous studies show a strong link between HLA-B51 and BD across various ethnic groups.
Purpose of the Study:
- To investigate the association between HLA-B51 alleles and BD in the Greek population.
- To explore the influence of sex, age of onset, and disease severity on this association.
- To identify specific HLA alleles predisposing to BD in a distinct ethnic cohort.
Main Methods:
- A case-control study involving 62 Greek BD patients and 87 controls.
- Serological HLA Class-I typing using microlymphocytotoxicity.
- HLA-DNA typing for the B5 group via PCR-SSO.
Main Results:
- The B*5101 allele was significantly more frequent in BD patients (80%) than controls (26%), with an odds ratio (OR) of 10.48.
- B*5101 was associated with an earlier age of BD onset and a higher risk of erythema nodosum (OR = 11).
- Males carrying B*5101 had a higher BD risk (OR 16.97) compared to females (OR 5.74).
Conclusions:
- The HLA-B*5101 allele is a significant predisposing genetic marker for Behçet's disease in the Greek population.
- This allele is linked to earlier disease onset and the development of erythema nodosum in both sexes.
- The findings reinforce the role of HLA-B51 in BD pathogenesis across diverse ethnic groups.